RXST

Rxsight Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth 5/10
  • Value 1/10
Rxsight sales and earnings growth
RXST Growth
Neutral
  • Revenue Y/Y -3.89%
  • EPS Y/Y -33.80%
  • FCF Y/Y 13.60%
Rxsight gross and profit margin trends
RXST Profitability
Low
  • Gross margin 76.60%
  • EPS margin -29.00%
  • ROIC 5Y -19.47%
Rxsight net debt vs free cash flow
RXST Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -2045.2

Rxsight stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗